Andreas Halvorsen’s Sanofi SNY Stock Holding History

Andreas Halvorsen’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-326,290	Closed	-$15.8M	–	102
2024 Q2	$15.8M	Buy	+326,290	New	+$15.7M	0.06%	80

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Andreas Halvorsen's SNY Position: Q3 2024 in Review

Andreas Halvorsen sold out of Sanofi (SNY) in Q3 2024, closing a stake of 326,290 shares — an estimated $15.8M sold.

Andreas Halvorsen first reported a position in SNY in Q2 2024 and held it in 1 quarter. The position peaked at $15.8M in Q2 2024. 758 funds tracked by Wall St. Rank hold SNY as of Q3 2024.

Andreas Halvorsen reported no remaining Sanofi position as of Q3 2024 after selling out during the quarter.
Andreas Halvorsen sold 326,290 Sanofi shares in Q3 2024, an estimated $15.8M.
Andreas Halvorsen first reported a position in Sanofi in Q2 2024 and held it in 1 quarter.
Andreas Halvorsen's Sanofi position peaked at $15.8M in Q2 2024.
758 funds tracked by Wall St. Rank held Sanofi as of Q3 2024.

Based on Viking Global Investors's 13F filing for Q3 2024, filed 14 Nov 2024.